Treatment of vascular thrombosis with enoxaparin in orthotopic heart transplant patients during the early postoperative period

John C. Lopshire, Alejandra G. Darroca, Irmina Gradus-Pizlo, Jacqueline A. O'Donnell

Research output: Contribution to journalArticle

1 Scopus citations


Management of anti-coagulation in the early period after orthotopic heart transplantation, when the frequency of invasive procedures to assess for graft rejection is high, presents a difficult clinical problem in which the need for effective therapy must be weighed against the desire for outpatient treatment. In this report, we summarize the clinical course and long-term outcome of 6 patients from our center in whom vascular thrombosis was treated on an outpatient basis with enoxaparin. We conclude that the use of enoxaparin may provide a safe and reasonable alternative to conventional anti-coagulation therapy during this period.

Original languageEnglish (US)
Pages (from-to)1025-1029
Number of pages5
JournalJournal of Heart and Lung Transplantation
Issue number9
StatePublished - Sep 17 2001


ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine
  • Transplantation

Cite this